China Shineway Pharmaceutical Group Limited Financial Overview
China Shineway Pharmaceutical Group Limited's market cap is currently HK$6.16B. The company's EPS TTM is HK$0.8855933633999999; its P/E ratio is 6.89; and it has a dividend yield of 6.20%. China Shineway Pharmaceutical Group Limited is scheduled to report earnings on August 27, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Currency in CNY
China Shineway Pharmaceutical Group Limited Earnings and Revenue History
